Services / Inspection readiness

Inspection readiness

Inspection-readiness assessments

Inspection readiness is whether people and documents tell the same story under time pressure. CliniGene assembles the narrative and the war-room index with AI, then runs mock front-room / back-room drills. Findings are written by reviewers who have sat in those rooms. We do not invent a regulatory opinion or predict a 483.

The problem this process is built for

Teams prepare binders that nobody can retrieve in four minutes. SMEs give answers that contradict the TMF. The computer-system story (Part 11, audit trail, who can pull it) was never rehearsed. Previous commitments from a 483 or a sponsor audit are forgotten until the inspector opens with them.

A “readiness deck” without a war-room index and a mock is theater. The work is: what will they ask, where is the artifact, who speaks, what do we do when the artifact is weak.

AI is fast at compiling history (deviations, safety themes, prior findings) into a draft narrative and pairing questions to paths. It must not be the voice in the front room.

What this has to survive

The first hour is a story test: do leadership, the TMF, and the system demo agree? Readiness means a retrieval path and a person who has been interrupted mid-answer — not a binder nobody can find.

Standards we score against

  • Applicable inspectorate practice (FDA BIMO / PAI, EMA, MHRA, or sponsor QA)
  • ICH-GCP and your SOPs for the scoped process
  • Prior commitments, 483s, CAPAs, and audit findings still open
  • eTMF / QMS / validation evidence paths
  • Your inspection SOP (front room, back room, scribe, hold)

Where teams get stuck

  • No single narrative — each function has a different story
  • Document retrieval over 10 minutes or “we will email it”
  • SMEs who have never been interrupted mid-answer
  • Audit trail demo that only one IT person can perform
  • Open CAPAs from the last inspection with no evidence of effectiveness

Who it is for

Quality, clinical, regulatory, site, and system owners facing FDA, EMA, MHRA, or sponsor inspection — notified, for-cause, or an annual readiness cycle.

What AI does — and does not do

On inspection work, AI compiles a draft narrative, question-to-path map, and commitment tracker from the packs you provide. Experienced reviewers run the mock and write findings. AI is not the voice in the front room. AI drafts maps, flags, first-pass language, and punch lists. A named specialist accepts, edits, or dismisses every official finding. AI does not sign a quality record, approve a vendor, freeze Vault, or speak in an inspection.

Questions on fit? hello@clini-gene.com or the contact form.

When to start this process

Start 6–10 weeks before a plausible notification for a study/sponsor mock; earlier for PAI-style site-plus-systems. If the letter already arrived, we still run a compressed war-room index and retrieval drill — we will be honest about what will not close in time.

If GCP maps, eTMF QC, CSV/CSA, or vendor files are too thin, we will say the mock will expose that and recommend those services in parallel.

What this is not

  • Predicting or guaranteeing a 483 / inspection outcome
  • Speaking as your SME in a real inspection unless separately engaged and allowed by your SOP
  • Inventing a regulatory opinion
  • A readiness deck with no war-room index and no mock
AI in this process

How the model is used, layer by layer

Each layer has a human gate. AI does not write the official quality record.

Narrative harvest

Protocol deviations, safety summaries you provide, CAPA log, previous findings → draft “what they will want explained first.” Specialists edit tone and cut speculation.

Question-to-path map

Likely questions paired with TMF ID, SOP number, VP/report, or system screen. Missing path = readiness gap.

Commitment tracker

Prior 483 / audit items vs. current evidence. Still open is a finding before the inspector arrives.

Interview notes

Optional transcription and theme tags after the mock. Scoring of answers is human.

Closeout plan

Day-by-day list for 30 days: who files what. AI can keep the list; owners are named by you.

Want this process walked on your trial or system?

Send the study, Vault, vendor, or inspection window. We will say what we need and what a first pass looks like.

hello@clini-gene.com

End-to-end process

Step-by-step: from intake to re-check

  1. 1

    Inspection profile

    Authority, scope (study, site, sponsor system, vendor), dates, and known history. Write what “ready” means for this event.

  2. 2

    Harvest and narrative

    AI draft + specialist edit. This becomes the briefing the leadership team shares — one story.

  3. 3

    War-room index

    Every likely question → artifact path. Gaps become the punch list (and often feed eTMF review and GCP mapping).

  4. 4

    Room and access rehearsal

    Who sits where, who scribes, how a document is requested, how an audit trail is pulled, who says “we will get that.”

  5. 5

    Mock interviews

    Front room / back room. We interrupt, ask for the document, and compare the spoken answer to the file. Contradictions are findings.

  6. 6

    System / facility tour

    For PAI or computer-system scope: rooms, access, backup, clock sync, account provisioning. Gaps on the same register.

  7. 7

    Score and briefing book

    Readiness score by theme (consent, oversight, IP, safety, data integrity, systems, prior commitments). Briefing book the team can actually use.

  8. 8

    30-day closeout

    Owned tasks. We can re-score the index after close. We do not claim you will have zero observations.

What a typical engagement looks like

Setting. Typical: sponsor inspection possible in 6–10 weeks, one pivotal study, prior CRO audit with three open CAPAs, Vault eTMF, SaaS EDC.

What we do. Narrative + war-room index from TMF/QMS/validation, two-day mock, system-access drill, score, 30-day plan tied to eTMF punch list and GCP CAPAs.

What you can show. The team has one story, a retrieval path, and a list of what is still weak — before the letter arrives.

Time

A focused study/sponsor mock is often 4–8 weeks including the drill. A full PAI-style readiness for a site plus systems is longer and should start before the notification, not after.

How a typical calendar runs

  1. Week 0. Inspection profile: authority, scope, dates, history. What “ready” means. Who may speak.
  2. Week 1–2. Harvest. Draft narrative. Question-to-path map. Commitment tracker vs. open CAPAs.
  3. Week 2–4. War-room index. Gaps become the punch list (often into eTMF and GCP work).
  4. Week 4–6. Room rehearsal. Mock interviews. System/access drill. Score by theme.
  5. Week 6–8. Briefing book. 30-day owned closeout. Optional re-score after close. No pass/fail prophecy.

What we need from you

  • Inspection SOP and proposed attendees
  • Protocol family, org chart, quality manual
  • Prior inspections/audits and open CAPAs
  • eTMF / QMS / validation access or exports
  • Who may speak in the front room

You receive

  • Inspection narrative (one story) and likely-question map
  • War-room document index with paths
  • Mock findings, contradictions, and readiness score
  • System/access drill notes
  • 30-day owned closeout plan and briefing book

Questions we hear first

Will you tell us we will pass?
No. We score readiness and list gaps. Inspection outcomes are not something we predict or guarantee.
Do you sit in the real inspection?
Only if you engage us for that and your SOP allows consultants in the room. The assessment itself is the mock and the pack.
How does this use the other services?
GCP mapping, eTMF quality review, CSV/CSA, and vendor files are the usual inputs. We will say so if those packs are too thin to rehearse.
FDA, EMA, MHRA, or sponsor QA — does the mock change?
The profile changes (BIMO vs PAI vs sponsor). The method does not: one narrative, paths, mock, score, closeout. We will not run a generic “inspection 101.”
What if we only have two weeks?
We compress to war-room index, retrieval drill, and the contradictions we can find. We will list what a 6-week program would still have done.
Do you provide scribes or front-room staff for the real inspection?
Only under a separate engagement and your inspection SOP. The assessment itself is the mock and the pack.

Start with Inspection-readiness assessments

Email hello@clini-gene.com or use the form. Mention Inspection-readiness assessments so we route it correctly.

hello@clini-gene.com

Talk with us about Inspection-readiness assessments

Email hello@clini-gene.com or send this form. The process is already selected.

Tell us the trial, Vault, vendor, or inspection date and what “done” looks like.

Send a message

Email hello@clini-gene.com if you prefer not to use the form.

See Privacy. We reply with how we can help and what we need next.

Veeva managed services

Run Vault after go-live: administration, releases, change control, and delta validation — with AI watching drift and tickets, and your system owner still approving production changes.

Learn more →

CSV and CSA

Apply GAMP 5 and FDA computer software assurance so testing follows patient-safety and data-integrity risk — not a copy-paste IQ/OQ/PQ for every screen.

Learn more →

eTMF quality review

Reconcile the electronic TMF to the TMF plan and milestones — completeness, QC, and inspectability — with AI pre-checks and TMF specialists issuing the official metric.

Learn more →